Pierre Sinet
About Pierre Sinet
Pierre Sinet serves as the Senior Medical Director for Cell Therapy at Kite Pharma in France. He has extensive experience in hematology and has held various roles at Janssen Pharmaceutical Companies and Merck Serono.
Current Role at Kite Pharma
Pierre Sinet serves as the Senior Medical Director for Cell Therapy France at Kite Pharma. He has held this position since 2023, working from Boulogne-Billancourt, Île-de-France, France. In this role, he is responsible for overseeing medical strategies and initiatives related to cell therapy, contributing to the advancement of innovative treatment options.
Previous Experience at Janssen Pharmaceuticals
Prior to his current role, Pierre Sinet worked at The Janssen Pharmaceutical Companies of Johnson & Johnson. He served as Medical Director for Global Medical Affairs in Hematology from 2020 to 2023. Before that, he held the position of MSL Manager in Hematology from 2017 to 2020 and worked as a Medical Advisor in Hematology from 2013 to 2017. His tenure at Janssen spanned nearly a decade, focusing on hematological therapies.
Early Career at Merck Serono
Pierre Sinet began his professional career at Merck Serono, where he worked as a Valorisation Économique, Scientifique et Market Access intern for five months in 2012. This experience provided him with foundational knowledge in economic valuation and market access strategies within the pharmaceutical industry.
Educational Background
Pierre Sinet holds a Docteur en Pharmacie degree from Université de Bourgogne, Faculté de Pharmacie de Dijon, which he obtained from 2006 to 2012. He also completed two Master 2 programs: one in Économie et Gestion de la Santé at Université Paris Dauphine - PSL from 2012 to 2013, and another in Santé Publique with a specialization in Évaluation en Santé-Recherche Clinique at Université Claude Bernard Lyon 1 from 2011 to 2012.
Pharmacy Experience at CHU de Dijon
In 2011, Pierre Sinet gained practical experience as an Externe en Pharmacie at CHU de Dijon. This role lasted for five months and allowed him to apply his academic knowledge in a clinical setting, enhancing his understanding of pharmacy practices.